| Topamax Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Topamax 25 mg | tablet | oral | 1.0 each | OTC |
| Topamax 100 mg | tablet | oral | 1.0 each | OTC |
| Topamax 200 mg | tablet | oral | 1.0 each | OTC |
| Topamax 50 mg | tablet | oral | 1.0 each | OTC |
Posted by suzieq1958 about 16 hours ago
I was placed on Topamax, off label, for suspected bipolar illness (now disproven). My cognition, word finding abilities, memo...
Posted by msb406 5 days ago
Ive been on Topamax since for 3 months for migraines and have lost 30 pounds, I simply am not hungry. At this point its not w...
Posted by funsunflower 12 days ago
I have recently started taking 100mg of topamax daily and the tingling in the bottom of my feet has been painful and keeping ...
Study Finds IONSYS™, A New Needle-Free System For Management Of ... - Medical News Today (press release)
... CONCERTA® (ADHD), EPREX® (anaemia), SPORANOX® (fungal infections), VELCADE® (multiple myeloma), PARIET® (gastroenterology), TOPAMAX® (epilepsy), ...
Mon Mar 10 03:09:06 -0400 2008
Study finds IONSYS (TM), a New Needle-Free System for Management ... - PR Newswire UK (press release)
... SPORANOX(R) (fungal infections), VELCADE(R) (multiple myeloma), PARIET(R) (gastroenterology), TOPAMAX(R) (epilepsy), REMINYL(R) (Alzheimer's disease), ...
Tue Mar 04 01:06:57 -0500 2008
Benefiting From 2008's Generic Drugs - Motley Fool
Other blockbusters losing their patent protection in 2008 include Johnson & Johnson's (NYSE: JNJ) Topamax, which Barr Labs and Mylan (NYSE: MYL) are set to ...
Thu Feb 28 14:45:19 -0500 2008
topiramate - A sulfamate-substituted monosaccharide with anticonvulsant property. Although the mechanism of action has not been fully elucidated, topiramate antagonizes kainate/AMPA subtype of the glutamate receptors, which are ligand-activated cation channels that mediate the fast component of excitatory postsynaptic currents in neurons of the central nervous system. This antagonistic action results in stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing propagation of synaptic impulses, thereby impedes seizure occurrences. In addition, this agent augments gamma-aminobenzoic acid (GABA) activity and thereby attenuating GABAnergic inhibitory transmission.